Posts in tag

alert


No recall for Boehringer Ingelheim’s Spiriva Respimat Solution for Inhalation 2.5μg, despite issues with the product’s inhaler device   Patients are being urged to continue using Boehringer Ingelheim’s Spiriva Respimat …

Imported “male enhancement supplement” poses safety risk to patients, regulator warns  Consumers using a supplement branded as Bull Blood tablets are being urged to stop taking it and hand over …

Bondi Sands mist product has incorrect usage directions, says regulator The Therapeutic Good Administration (TGA) has issued a product defection correction warning consumers to not spray a Bondi Sands sunscreen …

NSW Health issues warning over fentanyl-related substances NSW Health has issued a warning after strong opioids fentanyl and acetylfentanyl were recently identified as likely adulterants in cocaine or ketamine, leading …

TGA warns off advertising for first aid creams containing a cancelled NSAID  The Therapeutic Goods Administration (TGA) is reminding advertisers that first aid creams containing bufexamac cannot be advertised to …

TGA warns that the tablets contain undeclared sildenafil The TGA has tested a product labelled V-MAX herbal tablets and found that it contains undeclared sildenafil. “Consumers are advised that sildenafil …

A counterfeit benzodiazepine that is stamped to look like a pharmaceutical product is being illegally sold in Australia Etizolam, an unregistered benzodiazepine medication, is being illegally sold in Australia in …

The TGA has advised that it is monitoring the safety of Arthrem capsules due to concerns over a potential liver risk Arthrem capsules, marketed as a natural dietary supplement for …

Manufacturing issues lead to shortage of popular impetigo remedy The TGA is advising health professionals and consumers that there is a shortage of Bactroban (mupirocin) 20 mg/g ointment tubes. Bactroban …